Effects of Cognitive and Emotional Functioning on Treatment Outcomes (CEO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03050632 |
Recruitment Status :
Withdrawn
(With change of personnel and lab resources, this study was not feasible without independent funding)
First Posted : February 13, 2017
Last Update Posted : July 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The investigators are interested about the degree to which individuals can persist with individualized treatment goals when their cues (external such as food, or internal such as anxiety) are high for impulsive/maladaptive behavior (e.g., purging, not eating, etc.). The investigators want to find specific high-difficulty situations in which to assess whether participants remain mindful of the big picture and are willing to work toward therapeutic goals. Also, the investigators want to rate the participants degree of success (e.g., proportion of calories eaten) assessed more objectively.
The theory is that working memory capacity (WMC) modulates the ability to keep longer-term goals in mind when faced by current stress/temptations. For example, the ability to control drinking when one has an implicit urge to drink is predicted by WMC. The ability to apply a novel emotional regulation skill at a time of stress is also predicted by WMC. Indeed, the generic ability to pursue goals in the future (as assessed by the discounting of the value of future goals) is reliably predicted by WMC. There is also evidence that activation of brain regions associated with WMC (by direct activation of the dorsolateral prefrontal cortex via transcranial magnetic stimulation (TMS), or by having a person complete a relevant cognitive task) improves delay discounting.
Accordingly, the investigators are proposing a study that both assesses the link between WMC and relevant the clinical measures noted above, as well as changes in these measures following activation of WM with a cognitive prime (WM task). The overall design calls for an initial WMC assessment, followed by randomization to complete 3 days of a WM prime and then 3 days of a no prime group, or vice versa. The investigators then assess the clinical outcomes noted above across the following 6 days, with a WM prime first or no prime first occurring prior to the targeted behaviors. The investigators will prime WM prior to participant's evening meal, with the WM intervention offered during the free time before this meal.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Eating Disorders | Behavioral: N-back Behavioral: White Bear Task | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | An Investigation of the Effects of Cognitive and Emotional Functioning on Treatment Outcomes |
Estimated Study Start Date : | September 2019 |
Estimated Primary Completion Date : | November 2022 |
Estimated Study Completion Date : | December 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: Working Memory Intervention (N-back)
Participants will complete the working memory priming task either for the first 3 days of the intervention or the last 3 days of the intervention, with order counterbalanced across participants. The working memory prime is the N-back test, a measure of working memory in which individuals need to make a response to targets which are repeated letters either in a row (i.e., one-back) or in every-other-letter format (i.e., two-back) (Jaeggi et al., 2010).
|
Behavioral: N-back
The N-back task is a measure of working memory in which individuals need to make a response to targets which are repeated letters either in a row (i.e., one-back) or in every-other-letter format (i.e., two-back). |
Placebo Comparator: "White Bear" Task
Participants will complete this non-working-memory control task either for the first 3 days of the intervention or the last 3 days of the intervention, depending on counterbalanced order. The task consists of a procedure developed by Wegner and colleagues (1987) in a study of thought suppression, which instructs participants to inhibit thoughts of a white bear, and to indicate with a pencil mark every time the thought of the white bear occurs to them.
|
Behavioral: White Bear Task
For this thought suppression task, participants are instructed to inhibit thoughts of a white bear, and to indicate with a pencil mark every time the thought of the white bear occurs to them. |
- Meal Compliance [ Time Frame: Comparison of day 5 to day 8 scores taking into account intervention type, intervention order, and baseline scores ]Therapeutic Food and Snack Log.
- Mood [ Time Frame: Comparison of day 5 to day 8 scores taking into account intervention type, intervention order, and baseline scores ]Mood Monitoring Form
- Delay Discounting [ Time Frame: Comparison of day 5 to day 8 scores taking into account intervention type, intervention order, and baseline scores ]Monetary-Choice Questionnaire
- Eating Disorder Symptoms [ Time Frame: Comparison of day 5 to day 8 scores taking into account intervention type, intervention order, and baseline scores ]Eating Disorder Diagnostic Scale (EDDS)
- Depression [ Time Frame: Comparison of day 5 to day 8 scores taking into account intervention type, intervention order, and baseline scores ]Center for Epidemiologic Studies Depression Scale (CES-D)
- Depression, Anxiety, and Stress [ Time Frame: Comparison of day 5 to day 8 scores taking into account intervention type, intervention order, and baseline scores ]Depression Anxiety Stress Scales (DASS-21)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Residential patients
- Females 18 and older
- Able to provide informed consent for the study
- Sufficient command of the English language
- Have experience using a computer and mouse
- Diagnosed with an Eating Disorder
Exclusion Criteria:
None

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03050632
United States, Massachusetts | |
Boston University | |
Boston, Massachusetts, United States, 02215 |
Responsible Party: | Michael Otto, Professor of Psychology, Boston University Charles River Campus |
ClinicalTrials.gov Identifier: | NCT03050632 |
Other Study ID Numbers: |
4209 |
First Posted: | February 13, 2017 Key Record Dates |
Last Update Posted: | July 10, 2019 |
Last Verified: | July 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
working memory adherence |
Feeding and Eating Disorders Mental Disorders |